Literature DB >> 28784756

Glycine receptor α3 and α2 subunits mediate tonic and exogenous agonist-induced currents in forebrain.

Lindsay M McCracken1, Daniel C Lowes2, Michael C Salling1, Cyndel Carreau-Vollmer1, Naomi N Odean1, Yuri A Blednov3, Heinrich Betz4, R Adron Harris3, Neil L Harrison5,2.   

Abstract

Neuronal inhibition can occur via synaptic mechanisms or through tonic activation of extrasynaptic receptors. In spinal cord, glycine mediates synaptic inhibition through the activation of heteromeric glycine receptors (GlyRs) composed primarily of α1 and β subunits. Inhibitory GlyRs are also found throughout the brain, where GlyR α2 and α3 subunit expression exceeds that of α1, particularly in forebrain structures, and coassembly of these α subunits with the β subunit appears to occur to a lesser extent than in spinal cord. Here, we analyzed GlyR currents in several regions of the adolescent mouse forebrain (striatum, prefrontal cortex, hippocampus, amygdala, and bed nucleus of the stria terminalis). Our results show ubiquitous expression of GlyRs that mediate large-amplitude currents in response to exogenously applied glycine in these forebrain structures. Additionally, tonic inward currents were also detected, but only in the striatum, hippocampus, and prefrontal cortex (PFC). These tonic currents were sensitive to both strychnine and picrotoxin, indicating that they are mediated by extrasynaptic homomeric GlyRs. Recordings from mice deficient in the GlyR α3 subunit (Glra3-/-) revealed a lack of tonic GlyR currents in the striatum and the PFC. In Glra2-/Y animals, GlyR tonic currents were preserved; however, the amplitudes of current responses to exogenous glycine were significantly reduced. We conclude that functional α2 and α3 GlyRs are present in various regions of the forebrain and that α3 GlyRs specifically participate in tonic inhibition in the striatum and PFC. Our findings suggest roles for glycine in regulating neuronal excitability in the forebrain.

Entities:  

Keywords:  Cys-loop receptor; alpha subunits; glycine receptor; strychnine; tonic inhibition

Mesh:

Substances:

Year:  2017        PMID: 28784756      PMCID: PMC5576794          DOI: 10.1073/pnas.1703839114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  68 in total

1.  Single-channel properties of synaptic and extrasynaptic GABAA receptors suggest differential targeting of receptor subtypes.

Authors:  S G Brickley; S G Cull-Candy; M Farrant
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

2.  The excitation and depression of spinal neurones by structurally related amino acids.

Authors:  D R CURTIS; J C WATKINS
Journal:  J Neurochem       Date:  1960-09       Impact factor: 5.372

3.  Alterations in brain extracellular dopamine and glycine levels following combined administration of the glycine transporter type-1 inhibitor Org-24461 and risperidone.

Authors:  Katalin Nagy; Bernadett Marko; Gabriella Zsilla; Peter Matyus; Katalin Pallagi; Geza Szabo; Zsolt Juranyi; Jozsef Barkoczy; Gyorgy Levay; Laszlo G Harsing
Journal:  Neurochem Res       Date:  2010-08-20       Impact factor: 3.996

4.  Glycine release from astrocytes via functional reversal of GlyT1.

Authors:  Koji Shibasaki; Nobutake Hosoi; Ryosuke Kaneko; Makoto Tominaga; Katsuya Yamada
Journal:  J Neurochem       Date:  2016-08-09       Impact factor: 5.372

5.  Distribution of some synaptic transmitter suspects in cat spinal cord: glutamic acid, aspartic acid, gamma-aminobutyric acid, glycine and glutamine.

Authors:  L T Graham; R P Shank; R Werman; M H Aprison
Journal:  J Neurochem       Date:  1967-04       Impact factor: 5.372

6.  GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization.

Authors:  Robert J Harvey; Ulrike B Depner; Heinz Wässle; Seifollah Ahmadi; Cornelia Heindl; Heiko Reinold; Trevor G Smart; Kirsten Harvey; Burkhard Schütz; Osama M Abo-Salem; Andreas Zimmer; Pierrick Poisbeau; Hans Welzl; David P Wolfer; Heinrich Betz; Hanns Ulrich Zeilhofer; Ulrike Müller
Journal:  Science       Date:  2004-05-07       Impact factor: 47.728

Review 7.  Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations.

Authors:  Thomas Klausberger; Peter Somogyi
Journal:  Science       Date:  2008-07-04       Impact factor: 47.728

8.  Vesicular storage of glycine in glutamatergic terminals in mouse hippocampus.

Authors:  E Muller; W Bakkar; M Martina; A Sokolovski; A Y C Wong; P Legendre; R Bergeron
Journal:  Neuroscience       Date:  2013-03-16       Impact factor: 3.590

9.  A role for ligand-gated ion channels in rod photoreceptor development.

Authors:  Tracy L Young; Constance L Cepko
Journal:  Neuron       Date:  2004-03-25       Impact factor: 17.173

10.  Splice-specific roles of glycine receptor alpha3 in the hippocampus.

Authors:  Sabrina A Eichler; Benjamin Förstera; Birthe Smolinsky; René Jüttner; Thomas-Nicolas Lehmann; Michael Fähling; Günter Schwarz; Pascal Legendre; Jochen C Meier
Journal:  Eur J Neurosci       Date:  2009-09-01       Impact factor: 3.386

View more
  23 in total

Review 1.  A Critical Evaluation of Current Concepts in Cerebral Palsy.

Authors:  Joline E Brandenburg; Matthew J Fogarty; Gary C Sieck
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  Influence of nonsynaptic α1 glycine receptors on ethanol consumption and place preference.

Authors:  Braulio Muñoz; Scarlet Gallegos; Christian Peters; Pablo Murath; David M Lovinger; Gregg E Homanics; Luis G Aguayo
Journal:  Addict Biol       Date:  2019-03-18       Impact factor: 4.280

3.  Ethanol consumption and sedation are altered in mice lacking the glycine receptor α2 subunit.

Authors:  Loreto San Martin; Scarlet Gallegos; Anibal Araya; Nicol Romero; Giovanni Morelli; Joris Comhair; Robert J Harvey; Jean-Michel Rigo; Bert Brone; Luis G Aguayo
Journal:  Br J Pharmacol       Date:  2020-06-30       Impact factor: 8.739

Review 4.  Alcohol and the Brain: Neuronal Molecular Targets, Synapses, and Circuits.

Authors:  Karina P Abrahao; Armando G Salinas; David M Lovinger
Journal:  Neuron       Date:  2017-12-20       Impact factor: 17.173

5.  Activation of glycine receptors in the lateral habenula rescues anxiety- and depression-like behaviors associated with alcohol withdrawal and reduces alcohol intake in rats.

Authors:  Wenting Li; Wanhong Zuo; Wei Wu; Qi Kang Zuo; Rao Fu; Liangzhi Wu; Haifeng Zhang; Michael Ndukwe; Jiang-Hong Ye
Journal:  Neuropharmacology       Date:  2019-06-27       Impact factor: 5.250

6.  Glycine attenuates cerebrovascular remodeling via glycine receptor alpha 2 and vascular endothelial growth factor receptor 2 after stroke.

Authors:  Zheng Chen; Xiang Wang; Haikang Liao; Tao Sheng; Panhong Chen; Hongchang Zhou; Yongliang Pan; Weiqin Liu; Hua Yao
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

7.  Taurine Suppression of Central Amygdala GABAergic Inhibitory Signaling via Glycine Receptors Is Disrupted in Alcohol Dependence.

Authors:  Dean Kirson; Christopher S Oleata; Marisa Roberto
Journal:  Alcohol Clin Exp Res       Date:  2019-12-17       Impact factor: 3.455

8.  The synthetic cannabinoid dehydroxylcannabidiol restores the function of a major GABAA receptor isoform in a cell model of hyperekplexia.

Authors:  Guichang Zou; Jing Xia; Qianqian Han; Dan Liu; Wei Xiong
Journal:  J Biol Chem       Date:  2019-11-22       Impact factor: 5.157

9.  Skeletal muscle transcriptional networks linked to type I myofiber grouping in Parkinson's disease.

Authors:  Kaleen M Lavin; Stuart C Sealfon; Merry-Lynn N McDonald; Brandon M Roberts; Katarzyna Wilk; Venugopalan D Nair; Yongchao Ge; Preeti Lakshman Kumar; Samuel T Windham; Marcas M Bamman
Journal:  J Appl Physiol (1985)       Date:  2019-12-12

10.  Reduced sedation and increased ethanol consumption in knock-in mice expressing an ethanol insensitive alpha 2 subunit of the glycine receptor.

Authors:  S Gallegos; L San Martin; A Araya; D M Lovinger; G E Homanics; L G Aguayo
Journal:  Neuropsychopharmacology       Date:  2020-05-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.